Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: The ARIC brain MRI study

Neuroepidemiology

Volumn 43, Issue 3-4, 2014, Pages 220-227

  Mayeda, Elizabeth R ^a   Haan, Mary N ^a   Neuhaus, John ^a   Yaffe, Kristine ^a,b   Knopman, David S ^c   Sharrett, A Richey ^d   Griswold, Michael E ^e   Mosley, Thomas H ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive decline; Diabetes; Epidemiology; Ethnicity

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; COGNITION ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DRUG USE; FASTING; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCESSING SPEED; VERBAL MEMORY; AGED; COMPLICATION; ETHNOLOGY; INCIDENCE; MEMORY; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PSYCHOLOGY; RISK FACTOR;

AFRICAN AMERICANS; AGED; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RISK FACTORS;

EID: 84911470249     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000366506     Document Type: Article

References (33)

1. Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA: Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2014; 2:246-255.
2. Cheng G, Huang C, Deng H, Wang H: Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012; 42:484-491.
3. Crane PK, Walker R, Larson EB: Glucose levels and risk of dementia. N Engl J Med 2013; 369:1863-1864.
4. Exalto LG, Biessels GJ, Karter AJ, et al: Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol 2013; 1: 183-190.
5. Centers for Disease Control and Prevention: National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
6. Werner CA: The Older Population: 2010. Washington, DC, US Census Bureau, 2011.
7. Palta P, Schneider AL, Biessels GJ, Touradji P, Hill-Briggs F: Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc 2014; 20:278-291.
8. Yaffe K, Falvey C, Hamilton N, et al: Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012; 69:1170-1175.
9. Spauwen PJ, Kohler S, Verhey FR, Stehouwer CD, van Boxtel MP: Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care 2012.
10. Nooyens AC, Baan CA, Spijkerman AM, Verschuren WM: Type 2 diabetes and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study. Diabetes Care 2010; 33:1964-1969.
11. Tuligenga RH, Dugravot A, Tabák AG, et al: Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol 2014; 2:228-235.
12. Centers for Disease Control and Prevention National Center for Health Statistics: Median Age at Diagnosis of Diabetes Among Adult Incident Cases Aged 18-79 Years, by Race/Ethnicity, United States, 1997-2011. 2013. http://www.cdc.gov/diabetes/statistics/age/fig4.htm (Accessed June 6, 2014).
13. Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH: Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care 2005; 28:2280-2288.
14. Knopman DS, Mosley TH, Catellier DJ, Coker LH: Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement 2009; 5:207-214.
15. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129:687-702.
16. Liao D, Cooper L, Cai J, et al: Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996; 27:2262-2270.
17. Mosley TH Jr, Knopman DS, Catellier DJ, et al: Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005; 64:2056-2062.
18. Knopman DS, Ryberg S: A verbal memory test with high predictive accuracy for dementia of the Alzheimer type. Arch Neurol 1989; 46: 141-145.
19. Wechsler D: Wechsler Memory Scale-Revised Manual. New York, NY, Psychological Corp., 1981.
20. Lezak MD: Neuropsychological Assessment, ed 2. New York, NY, Oxford University Press, 1983.
21. Cerhan JR, Folsom AR, Mortimer JA, et al: Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998; 44:95-105.
22. American Diabetes Association: Standards of medical care in diabetes - 2014. Diabetes Care 2014; 37(SUPPL. 1):S14-S80.
23. Guo X, Carlin BP: Separate and Joint Modeling of Longitudinal and Event Time Data Using Standard Computer Packages. The American Statistician 2004; 58:16-24.
24. von Elm E, Altman DG, Egger M, et al: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18:800-804.
25. Williams DR: Race and health: basic questions, emerging directions. Ann Epidemiol 1997; 7:322-333.
26. Glymour MM, Manly JJ: Lifecourse social conditions and racial and ethnic patterns of cognitive aging. Neuropsychol Rev 2008; 18: 223-254.
27. Byrd DA, Touradji P, Tang MX, Manly JJ: Cancellation test performance in African American, Hispanic, and White elderly. J Int Neuropsychol Soc 2004; 10:401-411.
28. Manly JJ: Race, Culture, Education, and Cognitive Test Performance Among Older Adults; in Hofer S, Alwin D (eds): Handbook of Cognitive Aging: Interdisciplinary Perspectives. Thousand Oaks, CA, SAGE Publications, Inc., 2008, pp 398-418.
29. Debette S, Seshadri S, Beiser A, et al: Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011; 77:461-468.
30. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA: Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004; 61:661-666.
31. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K: Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004; 164:1327-1333.
32. Comijs HC, Kriegsman DM, Dik MG, Deeg DJ, Jonker C, Stalman WA: Somatic chronic diseases and 6-year change in cognitive functioning among older persons. Arch Gerontol Geriatr 2009; 48:191-196.
33. van den Berg E, de Craen AJ, Biessels GJ, Gussekloo J, Westendorp RG: The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia 2006; 49:2015-2023.